149 related articles for article (PubMed ID: 9167004)
1. Laboratory tests for live attenuated poliovirus vaccines.
Wood DJ; Macadam AJ
Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
[TBL] [Abstract][Full Text] [Related]
2. New assays for the quality control of live oral poliovirus vaccine.
Furesz J; Levenbook I
Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new approaches to poliovirus vaccine neurovirulence tests.
Wood DJ
Dev Biol Stand; 1996; 86():79-83. PubMed ID: 8785995
[TBL] [Abstract][Full Text] [Related]
4. Neurovirulence.
Wood D
Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the neurovirulence of poliovirus by non-radioisotope molecular analysis to quantify genomic changes.
Horie H; Tano Y; Doi Y; Hashizume S
Biologicals; 1998 Dec; 26(4):289-97. PubMed ID: 10403032
[TBL] [Abstract][Full Text] [Related]
7. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
8. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
Minor PD
Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
[TBL] [Abstract][Full Text] [Related]
9. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the new control methods for oral poliomyelitis vaccine.
Grachev VP; Karganova GG; Rumyantsev AA; Ivanova OE; Eremeeva TP; Drozdov SG
Dev Biol (Basel); 2001; 105():211-7. PubMed ID: 11763330
[TBL] [Abstract][Full Text] [Related]
12. Live-attenuated strains of improved genetic stability.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Almond JW; Minor PD
Dev Biol (Basel); 2001; 105():179-87. PubMed ID: 11763326
[TBL] [Abstract][Full Text] [Related]
13. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
Furesz J; Contreras G
Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
Minor PD; Macadam AJ; Stone DM; Almond JW
Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
[No Abstract] [Full Text] [Related]
15. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
[TBL] [Abstract][Full Text] [Related]
16. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
Levenbook I; Nomura T
Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
[TBL] [Abstract][Full Text] [Related]
17. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
18. [Use of molecular biological method (MAPREC-test) for evaluating residual neurovirulence and genetic stability of oral poliovirus vaccine type 3].
Rumiantsev AA; Grachev VP; Kozlov VG; Karganova GG
Vopr Virusol; 2001; 46(6):11-5. PubMed ID: 11785380
[TBL] [Abstract][Full Text] [Related]
19. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
20. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus.
Lee C; Young C
Microb Pathog; 1998 Oct; 25(4):215-25. PubMed ID: 9817825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
